Trial Profile
Natural History of Atypical Morquio A Disease: a 5-years Prospective Study in a Series of 9 Adult Patients Followed in a Single Expert Center
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2023
Price :
$35
*
At a glance
- Drugs Elosulfase alfa (Primary)
- Indications Mucopolysaccharidosis IV
- Focus Therapeutic Use
- 20 Jul 2023 Planned number of patients changed from 9 to 10.
- 20 Jul 2023 Planned End Date changed from 1 Jul 2023 to 1 Jul 2027.
- 20 Jul 2023 Planned primary completion date changed from 1 Feb 2020 to 1 Feb 2025.